Wilson GJ, Church LWP, Kelley CF, Robinson ST, et al. HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines. J Infect Dis 2024 Dec 13:jiae558. doi: 10.1093.
PMID: 39671174